MIST (Milestone Pharmaceuticals) OCF Margin %: -6,744.96% (As of Mar. 2026)

What is Milestone Pharmaceuticals OCF Margin %?

Milestone Pharmaceuticals MIST -1.33% 26 OCF Margin % is -6,744.96% as of Mar. 2026. GuruFocus rates MIST with a GF Score™ of 26/100. The stock has 6 warning signs investors should review. Among 959 Biotechnology companies, Milestone Pharmaceuticals ranks worse than 86.34% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Milestone Pharmaceuticals's Cash Flow from Operations for the three months ended in Mar. 2026 was $-16.05 Mil. Milestone Pharmaceuticals's Revenue for the three months ended in Mar. 2026 was $0.24 Mil. Therefore, Milestone Pharmaceuticals's OCF Margin % for the quarter that ended in Mar. 2026 was -6,744.96%.

As of today, Milestone Pharmaceuticals's current OCF Yield % is -32.86%.

The historical rank and industry rank for Milestone Pharmaceuticals's OCF Margin % or its related term are showing as below:

MIST' s OCF Margin % Range Over the Past 10 Years
Min: -4642.4 Med: -2110.75 Max: -221.49
Current: -2866.7

During the past 9 years, the highest OCF Margin % of Milestone Pharmaceuticals was -221.49%. The lowest was -4642.40%. And the median was -2110.75%.

MIST's OCF Margin % is ranked worse than
86.34% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs MIST: -2866.70

Milestone Pharmaceuticals OCF Margin % Related Terms

Milestone Pharmaceuticals OCF Margin % Historical Data

* Premium members only.

The historical data trend for Milestone Pharmaceuticals's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Milestone Pharmaceuticals OCF Margin % Chart

Milestone Pharmaceuticals Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

OCF Margin %

Get a 7-Day Free Trial

-221.49

-1,049.38

-4,642.40

0.00

-3,172.12

Milestone Pharmaceuticals Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
OCF Margin %	Get a 7-Day Free Trial															0.00	0.00	0.00	-826.33	-6,744.96

MIST vs TLSA, DTIL, OKUR: OCF Margin % Comparison

For the Biotechnology subindustry, Milestone Pharmaceuticals's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Milestone Pharmaceuticals OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Milestone Pharmaceuticals's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Milestone Pharmaceuticals's OCF Margin % falls into.

Save Embed

26GF Score

Milestone Pharmaceuticals Inc MIST

OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Milestone Pharmaceuticals OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Milestone Pharmaceuticals's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin	=	Cash Flow from Operations (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-49.041	/	1.546
	=	-3,172.12 %

Milestone Pharmaceuticals's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin	=	Cash Flow from Operations (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-16.053	/	0.238
	=	-6,744.96 %

Frequently Asked Questions Learn more about OCF Margin % →

What does a OCF Margin % of -6,744.96% mean?

Milestone Pharmaceuticals (MIST) has a OCF Margin % of -6,744.96% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Milestone Pharmaceuticals and its competitors. According to the industry distribution chart, Milestone Pharmaceuticals ranks #828 out of 959 companies in the Biotechnology industry, placing it in the top 86.3%.

Is Milestone Pharmaceuticals' OCF Margin % too high?

Milestone Pharmaceuticals' current OCF Margin % is -6,744.96%. Based on the distribution chart, Milestone Pharmaceuticals ranks #828 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Milestone Pharmaceuticals has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.

How does Milestone Pharmaceuticals' OCF Margin % compare to TLSA and DTIL?

According to the Biotechnology industry distribution chart, Milestone Pharmaceuticals ranks #828 out of 959 companies for OCF Margin %. This places Milestone Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good OCF Margin % for a Biotechnology company?

A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high OCF Margin % mean?

A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Milestone Pharmaceuticals and its competitors. Milestone Pharmaceuticals's current OCF Margin % is -6,744.96%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Milestone Pharmaceuticals stock overvalued right now?

Milestone Pharmaceuticals (MIST) has a current OCF Margin % of -6,744.96%. The current OCF Margin % is -6,744.96%. Milestone Pharmaceuticals' overall GF Score™ is 26/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is OCF Margin % calculated?

OCF Margin % is calculated from a company's financial statements. For Milestone Pharmaceuticals (MIST), the current OCF Margin % is -6,744.96% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Milestone Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies TLSA DTIL OKUR EQ PLX MDWD GALT PRQR QTTB ABOS VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Address 1111 Dr. Frederik-Phillips Boulevard, Suite 420, Montreal, QC, CAN, H4M 2X6

Website https://www.milestonepharma.com

Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.

26GF Score

Get the complete analysis for MIST

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.25

Price

View MIST Analysis

See OCF Margin % data for all stocks →